TCTR20141128001CompletedPhase 1
Study the effects of Andrographis paniculata on platelet aggregation in Thai healthy volunteers: the pilot study
Faculty of Medicine Siriraj Hospital0 sites10 target enrollmentStarted: November 28, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 Years to 60 Years (—)
- Sex
- All
Inclusion Criteria
- •1. Male or female age between 25-60 years
- •2. Body mass index (BMI) between 18 to 24 kg/m^2
- •3. Who has been determined healthy physical examination, medical history, and vital signs
- •4. Female, non pregnant or use the contraceptive or not currently breast feeding and have negative pregnancy test
- •5. Who be willing to participate and signed the informed consent form
Exclusion Criteria
- •1. Who has history usage of other drugs, especially which can effect platelet aggregation
- •2. Who has history of allergic reactions or allergy to NSAIDs, Andrographis paniculata or its derivative compounds
- •3. Who is no smoke and alcohol
- •4. Who has donated blood within last 90 days before participate
Investigators
Similar Trials
Not yet recruiting
Phase 4
A clinical study to understand the combined effects of Andrographis & metformin, in comparison to metformin alone treatment on glycemic control in type 2 diabetes patientsCTRI/2019/11/021977Dr Anand Kumar Maurya
Completed
Phase 3
The efficacy and safety of Andrographis paniculata extract for the treatment of acute nonspecific upper respiratory tract infections: a randomized double-blind placebo controlled trialAcute nonspecific upper respiratory tract infections with one or more symptoms such as fever,sore throat,nasal congestion,dry infrequent cough and had modified Centor Score of 2 or less.Andrographis paniculataandrographolideacute nonspecific upper respiratory tract infectionspharyngitiscommon coldTCTR20170329002Department of Thai Traditional and Alternative Medicine829
Completed
Phase 1
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trialTCTR20210708001Thai Traditional Medicine Knowlegde funding63
Recruiting
Phase 3
Efficacy and safety of Andrographis paniculata extract for the treatment of asymptomatic or mild-symptoms COVID-19 patients: A double-blinded, randomized-control trialCOVID-19 patienrs, RT-PCR confirmedCovid-19 treatmentAndrographidis paniculatae extractPneumoniaTCTR20211224002Health System Research Institute736
Completed
Not Applicable
An investigation into the immunomodulating effects of Andrographis paniculata in healthy malesImmune function in healthy populationACTRN12617000186358Integria Healthcare (Australia) Pty Ltd.20